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Abstract
Computational models in biomedicine rely on biological and clinical assumptions. The selection of these assumptions
contributes substantially to modeling success or failure. Assumptions used by experts at the cutting edge of research,
however, are rarely explicitly described in scientific publications. One can directly collect and assess some of these
assumptions through interviews and surveys. Here we investigate diversity in expert views about a complex biological
phenomenon, the process of cancer metastasis. We harvested individual viewpoints from 28 experts in clinical and
molecular aspects of cancer metastasis and summarized them computationally. While experts predominantly agreed on the
definition of individual steps involved in metastasis, no two expert scenarios for metastasis were identical. We computed
the probability that any two experts would disagree on k or fewer metastatic stages and found that any two randomly
selected experts are likely to disagree about several assumptions. Considering the probability that two or more of these
experts review an article or a proposal about metastatic cascades, the probability that they will disagree with elements of a
proposed model approaches 1. This diversity of conceptions has clear consequences for advance and deadlock in the field.
We suggest that strong, incompatible views are common in biomedicine but largely invisible to biomedical experts
themselves. We built a formal Markov model of metastasis to encapsulate expert convergence and divergence regarding
the entire sequence of metastatic stages. This model revealed stages of greatest disagreement, including the points at
which cancer enters and leaves the bloodstream. The model provides a formal probabilistic hypothesis against which
researchers can evaluate data on the process of metastasis. This would enable subsequent improvement of the model
through Bayesian probabilistic update. Practically, we propose that model assumptions and hunches be harvested
systematically and made available for modelers and scientists.
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Introduction
When designing a mathematical model about a biological
phenomenon, the computational biologist typically follows several
paths in search of existing knowledge. She may consult textbooks,
scan for relevant research articles, evaluate the prior modeling
literature, seek advice from or collaborate with domain experts.
In most cases, the pool of all relevant publications is too vast to
read, leading to an idiosyncratic sample of viewpoints. Seeking
advice from expert colleagues, however, raises the same concern–
the unknown degree to which their views represent the
distribution of expert opinion across the field. Proper evaluation
of the uncertainty about domain knowledge has profound
empirical importance for scientific advance and model design
[1,2]. In the short run, improper selection of domain knowledge
would make it difficult for a scientist to convince reviewers and
readers about the validity of her approach. In the long run, a
model based on unpopular or dubious assumptions is less likely to
provide a useful predictive description regarding the phenome-
non of interest.
Imagine that a model-designer has time and energy to seek
advice from a broad sample of colleagues. How coherent is the
entire collection expert opinion? Would disagreement be reserved
for minor issues and consensus obtain for major ones? Would only
low-certainty issues be disputed, or would experts express certainty
about opposing answers to central questions? Finally, how can one
reliably measure these quantities? While answers to these questions
likely vary across domains, few studies in biomedicine or other
areas of science have addressed them [3–6].
A formal way to think about expert opinion is through the lens
of Bayesian statistics [7]. In comparing multiple mathematical
models of the same process, we can estimate the posterior
probability of a model given data. The model with the highest
posterior probability, given the same data, could be said to
‘‘describe’’ the data best. To compute the probability of a model
given data, we must specify prior distributions over models and
over model-specific parameters. Expert opinion is precisely what
should be the basis of these priors. If the amount of experimental
data is modest, strong prior distributions over parameter values
can profoundly affect the results of statistical analyses. Even more
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models. The results of analysis can be very different under distinct
models, and expert confidence in particular models dramatically
influences the interpretation of data.
Here we consider a somewhat neglected aspect of biomedical
modeling: scientific uncertainty about biological models. This
uncertainty only partially transpires in research publications. It
predominantly resides in experts’ minds and close conversations.
We note that in some fields, such as engineering, it is more
common to acquire expert opinion and employ probabilistic
models when limited information is available [8]. Even there,
however, the focus is on ascertaining modal opinion and not
estimating diversity and uncertainty. As a case study, we chose the
field of cancer metastasis: the spread of cancer cells from their
original location to new sites in the body.
Metastasis has enormous medical importance. In 2000 Hana-
han and Weinberg published a classic review article entitled ‘‘The
Hallmarks of Cancer’’ [9] in which they famously diagrammed six
functional capabilities that all cancers seem to share: (1) limitless
replicative potential, (2) sustained angiogenesis, (3) evading
apoptosis, (4) self-sufficiency in growth signals, (5) insensitivity to
anti-growth signals, (6) tissue invasion and metastasis. Among
these six hallmarks, metastasis plays the most prominent role in
determining a patient’s fate. If every malignancy remained at its
initial location, most solid cancers could be treated effectively with
surgery. Metastasis or the spread of cancer to multiple new
locations, however, makes it increasingly hard to track and remove
new colonies of afflicted cells. Eventually, the infestation becomes
so severe that nothing can be done for the patient beyond reducing
pain and administering toxic drugs to slow invasion. Developing
high-fidelity mathematical models of the multistage progression of
metastasis will be critical for finding new ways to slow or stop it—
for example, by identifying vulnerable steps in the process that
could be targeted by medicine.
The field of metastasis research is established but very
dynamic—over 80% of the literature on metastasis was published
during the last two decades and almost 60% in the last ten years—
making it an attractive subject for the design of computational
models and the assessment of (living) expert opinion. A field in
which knowledge claims are more established and stable would
admittedly be easier and more reliable to model, and yet such
models would unlikely contribute to scientific advance. Metastasis
is a complex phenomenon involving a wide community of active
researchers with diverse training. This necessarily increases the
diversity of opinion within the field, but creates opportunities for
modeling that contribute to advance by analytically juxtaposing
the consequences of different perspectives. We assessed prior
knowledge about metastasis by collecting and analyzing the views
of 28 experts. Our analysis has broad implications for modeling
biological and scientific phenomena in general, for exposing
scientific assumptions for evaluation and testing, for understanding
the complex process of peer-review, and for bridging disconnected
subfields of biomedicine.
Stages of metastasis and hypotheses
Theaccepted(‘‘textbook’’)viewofmetastasisincludesthefollowing
s t a g e s( s e eF i g u r e1 ) .A tt h eprimary stage, an individual renegade cell
becomes malignant, begins uncontrollable proliferation, learns to
avoid the immune system and anti-growth signals, and forms the
initial (primary) tumor with access to its own blood supply. This stage
is followed by a stage of detachment (migration), where tumor cells
disconnect from the primary colony to begin their journey through
the body. The next stage involves invasion, breach of the extracellular
membrane (ECM),a n dintravasation. At this stage the cancer cell has to
overcome several obstacles to actively reach and penetrate the wall of
a blood or lymph vessel (intravasation), gaining access to the body’s
transport system that would carry it to unaffected tissues. Next, blood
or lymph carries the cancer cell to new locations—the stage of
migration (transport). The extravasation stage is intravasation in reverse:
the cancer cell escapes the blood or lymph vessel that has carried it by
penetrating its wall and invades the new organ or tissue. This stage is
followed by colonization of the tissue/organ and cell proliferation.
Typically, early stages of this infestation are described as micrometas-
tasis, formation of a small secondary tumor, usually without its own
blood supply (no angiogenesis occurs at early stages) and with a
balance of proliferation and apoptosis. When the secondary tumor
manages to activate growth of its own blood vessels, it enters the stage
of macrometastasis, culminating in the growth of a large secondary
tumor.
While there is evidence that metastasis was recognized as early
as in 250 BCE in China, the term was coined in 1829 by French
gynecologist Joseph Recamier [10]. Since that time there have
been several important theories about metastasis and its role in the
progression of cancer. Some theories attempt to explain how
cancer cells gain metastatic potential—how they gain the ability to
detach from the base membrane, lose gap and tight junction
contacts with neighboring cells, migrate from primary tumor sites,
enter and survive in the vasculature or lymphatics before arrest in
the secondary site and proliferate within the vessel or, after
extravasation, into the surrounding tissue. The ‘‘fusion model’’
explains these abilities by suggesting that epithelial cells from solid
tumors somehow fuse with cells from lymphoid tissue (e.g.,
leukocytes) that possess many of these abilities or that tumor DNA
is taken up in the broader circulatory system. This follows from a
19
th Century finding that eggs experimentally fertilized with
multiple sperm underwent abnormal mitosis, which suggested
similar chromosomal imbalance might result in oncogenesis [11].
Alternately, Nowell proposed the ‘‘progression model’’ in 1976
that postulated a series of somatic mutational events required for a
cell to acquire a more embryonic phenotype that endowed it with
metastatic abilities [12]. As a result, only a small fraction of cells
stochastically acquire this ability. Other models suggest a broad
genetic predisposition that interacts with either a progression or
fusion mechanism [13]. The issue of when and how cancer cells
gain metastatic potential is one of the pending questions we
examine here.
Author Summary
Mathematical models and scientific theories fail not only
from internal inconsistency, but also from the poor
selection of basic assumptions. Assumptions in computa-
tional models of biomedicine are typically provided by
scientists who interact directly with empirical data. If we
seek to model the dynamics of cancer metastasis and ask
experts regarding valid assumptions, how widely will they
agree and on which assumptions? To answer this question,
we queried 28 faculty-level experts about the progression
of metastasis. We demonstrate an unexpected diversity of
assumptions across experts leading to a striking lack of
agreement over the basic stages and sequence of
metastasis. We suggest a formal model and framework
that builds on this diversity and enables researchers to
evaluate divergent hypotheses about metastasis with
experimental data. We conclude that modeling biomedical
processes could be substantially improved by harvesting
scientific assumptions and exposing them for formalization
and experiment.
Conflicting Assumptions about Metastasis
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relationship between primary and secondary tumor sites. Perhaps
the most famous is the ‘‘seed and soil’’ hypothesis, formulated by
Paget [14] in 1889 and based on the following metaphor: ‘‘When a
plant goes to seed, its seeds are carried in all directions… But they
can only live and grow if they fall on congenial soil’’ [14]. If cancer
cells are carried passively from the original tumor to secondary
locations, can they colonize any tissue they might encounter?
Paget analyzed more than seven hundred case histories of breast
cancer and found that metastases formed in the liver far more
often than in the spleen, but the spleen had nearly identical
exposure to cancer cells as the liver via blood flow. Therefore, the
liver must provide more ‘‘congenial soil’’ for breast cancer ‘‘seeds’’
than the spleen. This theory and others were eclipsed in the
genetics revolution beginning in the 1950s, when the dominant
paradigm in cancer research turned to investigation of ‘‘onco-
genes’’ that controlled cell growth. In the last decade, however,
many empirical demonstrations have convinced researchers of the
importance of Paget’s ‘‘soil’’, now redefined in molecular terms as
a tumor context or microenvironment required for secondary
tumor growth. The issue of secondary site selection, also known as
tropism, is another question we examine here.
We also explore expert views on the factors that affect other parts
of metastasis, from the entry of cancer cells into the blood stream
(intravasation) to the initial growth of secondary tumors (microme-
tastasis) to the recruitment of blood vessels by those tumors
(angiogenesis). We believe that understanding the distribution of
expert intuitions on these issues will expose their assumptions to
scrutiny and speed the creation of reliable formal models.
Materials and Methods
Interviews
We conducted individual interviews with 28 principal investi-
gators studying clinical and molecular aspects of metastasis.
Subjects were selected based on their expertise, professional
stature, and availability for interview. The interviews took place
between March 2008 and April 2009. Experts were recruited
through personal contacts and by asking interviewed experts to
recommend others at the close of our interview. Experts were
specialists in a number of different disciplines: breast, head and
neck, prostate, gastrointestinal, urinary, ovarian, and brain cancer;
melanoma, neuroblastoma, developmental biology, radiation
oncology, immunology, endocrine pathology, genetics, biochem-
istry, and the cell and molecular biology of cancer. They were
located in 10 institutions in four countries (USA, UK, Sweden and
Australia). All interviews with experts from the University of
Chicago were conducted in person and all others by telephone.
Prior to the interviews, we conducted four informal conversations
with four experts: one MD/PhD and three PhD scientists. These
exploratory pre-interviews were used to guide design of the study,
allowing us to explore and define topics of biological and clinical
interest. We linked these topics with description in scholarly articles
and used them as a basis for the remainder of the interviews.
Our semi-structured interviews had two parts. At the beginning
of each, we instructed interviewees to imagine an informal setting in
which they could comfortably share speculations and hunches. We
then asked experts to provide a definition of metastasis. Next, we
provided a diagram of metastatic progression (see Figures 2A and
3A). We explained that the diagram was simply a rough draft
intended to initiate discussion, and invited comments and edits. We
then asked additional questions to elicit observations and specula-
tions about metastasis and related controversies. In the second part
of the interview, we asked experts about specific topics derived from
the pre-interview pilot study. Particular questions of interest for
modeling metastasis are: When do cells acquire metastatic abilities?
What is the basis and the importance of tropism? What (if any) is the
relationship between metastasis, development and evolution?
Analysis of the interviews
All interviews were audio-recorded, transcribed and manually
annotated and converted into structured statements. These were
Figure 1. A ‘‘textbook’’ view of the metastatic progression of a malignant tumor. The tumor’s development starts with its growth at the
primary location (primary tumor). In metastatic progression, some cells from the primary tumor detach from the colony (detachment), enter blood or
lymph vessels (intravasation) and travel within the body (migration/transport). Next, the traveling cells exit blood or lymph vessels (extravasation) and
colonize new sites in the body. There, they divide and form tiny colonies at first (micrometastasis), followed by further cell proliferation, recruitment of
blood vessels (angiogenesis) that provide small colonies with sufficient nutrients to develop into large tumors (macrometastasis). It is currently unclear
if secondary colonies can re-metastasize to form tertiary and quaternary colonies (dotted line indicating a cyclic process).
doi:10.1371/journal.pcbi.1002132.g001
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or conviction, then linked to transcripts and expert identifiers.
Analysis of the non-uniformity of topics
In addition to qualitative analyses, we tested for non-uniformity
in the distribution of the ideas discussed by experts. The null
hypothesis in this analysis is that comments are distributed
randomly and uniformly across all topics. Under the null
hypothesis we can compute the expected number of ideas for
each topic and test differences between expected values (i.e.,
proportional attention) and observed values using a chi-squared
statistic with one degree of freedom:
x1
2~
(Ot{Et)
2
Et
z
(OT{t{ET{t)
2
ET{t
,
where the subscript t refers to the number of comments (ideas) per
selected topic, while T–t refers to the remaining comments with
this particular topic excluded. This calculation implies that the
whole collection of comments (ideas) is partitioned into two
unequal parts—those focused on t and those not (T-t). The
expected numbers of comments for each part are computed under
the hypothesis of a uniform distribution of comments over all
topics. To correct for multiple statistical testing for topic-wise
analysis, we used a conservative Bonferroni correction requiring a
pooled significance of p,0.05. We performed a similar analysis of
the distribution of comments among expert groups. The goal of
this analysis was to identify differences in expert responses across
topics and the variation of interest across expert groups.
Story similarity metrics
To quantify similarity and dissimilarity between pairs of experts,
we introduced a metric that compares two series of elements (see
Figure 4A). Imagine that two experts’ stories included events A, B,
C, D, and F, where each letter corresponds to one of the 26
metastasis stages that we or our informants proposed (see Figure 3).
One hypothetical expert (Expert 1 in Figure 4A) provided two
alternative stories, ABC and AFDC, and the other (Expert 2) only
one, ACBD. We first reduce each series to a set of ordered pairs
and then combine multiple series from the same expert into a set
of unique ordered pairs. These pairs include elements that abut
each other in the sequence (AB, BC, CD, etc.) as well as all
noncontiguous ordered elements (AC, AD, BD, etc.). Then, we
can define similarity (Sij) between two experts’ views (experts i and
j) as twice the number of ordered pairs common to the two sets
Figure 2. Visualization of expert views about the importance of canonical metastatic stages within the actual process of metastasis.
While commenting on the suggested diagram (see Figures 1 and 2A), most experts were not confident that certain stages proposed are part of the
metastatic process observed in the laboratory or clinic. Font size represents the number of experts voting for inclusion of the stage represented by
the corresponding phrase. (A) The schematic that we presented to experts as canonical. (B–D) Subgroups of experts: PhDs only (B), MDs only (C), MD/
PhDs (D). (E) The distribution of certainty across all experts.
doi:10.1371/journal.pcbi.1002132.g002
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PLoS Computational Biology | www.ploscompbiol.org 4 October 2011 | Volume 7 | Issue 10 | e1002132Figure 3. Metastatic cascades as viewed by individual experts. (A) The cascade that we presented to the experts as a ‘‘textbook’’ cascade.
Experts suggested reordering stages, removing certain stages and/or adding new ones. (B) Expert-specific depiction of metastasis progression
suggested during interviews. Note that every scenario is distinct. Expert 3 did not suggest any scenario, commenting that we have insufficient
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unmatched pairs of events from the two sets (see Figure 4A):
Dij~SiizSjj{2Sij
One could adjust Sij and Dij by weighting elements (and their
associated pairs) by claimed importance, but we neither sought nor
obtained unambiguous indications of import in the current
interviews.
Modeling agreement
In order to estimate the nature of expert agreement about the
sequence of events in metastasis [15,16], and also create a
standard against which experimental and observational data about
metastasis could be evaluated, we built a model that incorporates
all expert scenarios as special cases. Our model builds on the
simple yet powerful Markov chain formalism [17,18], which is
particularly appropriate given the sequential nature of metastasis.
A Markov chain is an ordered sequence of random variables X0,
X1,… ,XK, which correspond to the sequence of possible
metastatic events. Each of these variables can take values
(X0=x0, X1=x1,… ,XK=xK) from a set of states S={1, 2, …,
N} that correspond to the expert proposed stages of metastasis
(e.g., primary tumor, detachment, invasion, etc. such that
N=28—see labels associated with the matrix we discuss in
‘‘Integrating expert stories’’ under ‘‘Results’’).
The sequence of random variables follows a homogeneous
Markov process when
P(Xm~xmjXm{1~xm{1,Xm{2~xm{2,:::,X0~x0)
~P(Xm~xmjXm{1~xm{1)~rxm{1xm,
P(X0~y)~ly:
This implies that each metastatic stage depends only on the stage
immediately prior, and that the transition probabilities from one
stage to another do not vary across the sequence. In this way, the
Markov process is determined by a vector and a matrix
L~(l0,l1,:::,lN),
and
P~
r11 r12     r1N
r21 r22     r2N
        P    
rN1 rN2     rNN
0
B B B @
1
C C C A
:
where rij is the conditional probability of transition from stage i to
stage j so that
X N
j~1
j=i
rij~1;
0ƒrijƒ1:
(Note that in general, diagonal elements in a stochastic matrix
defining a Markov process can be positive. Because this analysis
focuses on the sequence of metastatic stages rather than the timing
involved in the transition between stages, we do not allow a
metastatic stage to transition to itself.)
P(X0~x0,X1~x1, :::,XK~xK)~lx0rx0x1rx1x2:::rxK{1xK:
We define N states of the process, and assume that it always starts
at artificially defined stage S (state 0), and always ends at another
artificially defined stage E (state N, where N=28). In other words,
we start in state S with probability 1 such that
L~(1,0,:::,0):
a n dw ea l w a y se n dt h ec h a i no n c es t a t eEi sr e a c h e ds u c ht h a tt h es t e a d y
state or stationary distribution vector of metastatic stages (p)i sd e f i n e da s
p~(0,0,:::,1):
For data with mi observed transitions from state i to any other state, the
s e to fo b s e r v e dc o u n t so ft r a n s i t i o n sa c r o s sa l le x p e r ts t o r i e s ,{ cij}, j=1,…,N
(where i?j) follows a multinomial distribution with expected values
{rij}, j=1,…,N
fcijgj~1,:::,N*Multinomial(fcijgj~1,:::,N;Ci):
P(ci1,:::,ciN;Cijri1,:::,riN)~
Ci
ci1,:::,ciN
 !
P
N
j~1
r
cij
ij ,
where
X N
j~1
cij~Ci:
The prior distribution of transition probabilities can then be defined by
a Dirichlet distribution
frijgi=j;iw0; j~1,:::,N*Dirichlet(
a
N{2
,:::,
a
N{2
):
f(ri1,:::,riNja)~
C(a)
P
N
j~1
C
a
N{2
hi P
N{1
k~1
r
ik
a
N{1:
As is customary in these applications [19], we assume that a$N-2 (e.g.,
a=1.1 N). The posterior distribution for rij then is also a conjugate
Dirichlet distribution
frijgj~1,:::,N*Dirichlet(
a
N{2
zci1,:::,
a
N{2
zciN):
The posterior expectation estimate of rij is given by
^ r rij
PE~
cijz
a
N{2
Ciza
:
knowledge; four experts suggested two possibilities (depicted as a pair of scenarios grouped by vertical bars). The ellipses (…) indicate that experts
agreed with the prior or posterior sequence that we showed them. (Supplementary Figure S1 demonstrates further variation provided by experts in
renaming stages.) (C) Additional stages/concepts that were not present in the original schematic (A) but were suggested by experts.
doi:10.1371/journal.pcbi.1002132.g003
Conflicting Assumptions about Metastasis
PLoS Computational Biology | www.ploscompbiol.org 6 October 2011 | Volume 7 | Issue 10 | e1002132Figure 4. Quantifying the agreement between expert scenarios of metastasis. (A) A hypothetical example of scenarios produced by two
experts (experts 1 and 2). Expert 1 suggested two alternative scenarios (ABC and AFDC), while expert 2 suggested only one (ACBD). We define the
agreement/similarity between experts as twice the number of stage pairs they share, of all possible ordered pairs of stages from each scenario. We
define the disagreement/dissimilarity as the agreement minus the sum of unmatched pairs; see the example. (B) Cumulative probabilities that two
experts agree at least at level x (similarity of x or greater), and that two experts disagree at level x or less. The probability of agreement drops rapidly
as the number of statements from each expert increases, while the probability of disagreement grows gradually to a rather large number of pairwise
disputes. (C) A hypothetical four-expert ‘‘regulatory deadlock’’ could occur if any one of the experts insisted on his disagreement with all others.
doi:10.1371/journal.pcbi.1002132.g004
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^ r rij MAP~
cijz
a
N{2
{1
Ciza{Nz2
,
a§N{2,
i=j, jw0:
Certification
The study was approved by the University of Chicago
Institutional Review Board.
Results
The interviews
We performed, digitally recorded, and transcribed into text 28
interviews with faculty-level experts in metastasis. The duration of
these interviews ranged from 15 minutes and 1,579 words to
93 minutes and 11,702 words, with a 39-minute, 4,497 word
average. The total duration of our recorded interviews is 18 hours
and 3 minutes or 125,916 words.
We grouped our experts in several ways, by the following traits.
First, we distinguished them by training background and
certification: 15 of our experts held only a PhD; 7 held only an
MD; and 6 were MD/PhDs. Second, we divided them by gender,
into groups of 19 males and 9 females. Third, we clustered our
experts by the period in which they received their first advanced
degree: before 1986 (9), between 1986 and 1995 (11), or after 1995
(8). Finally, to control for the context of our interviews, we
aggregated those conducted in person with experts from the
University of Chicago (16) versus those done over the telephone
with experts elsewhere (12).
Importance of steps in metastasis progression; ordering
steps
During our interviews we asked all 28 experts to comment on
‘‘our’’ scheme of metastasis progression. Figure 2A depicts a
slightly scrambled schematic of metastasis that we showed to
experts as the baseline, expecting corrections and rearrangements.
Experts described their understanding of the process, suggesting
additions, deletions, and event-ordering changes to the diagram.
The overall importance of different stages according to these
experts is illustrated in Figure 2B, C, D, and E. While they
generally accepted individual stages of the canonical model,
experts suggested additional details, rearrangements and clarifica-
tions. Biologists (PhDs, see Figure 2B) were more oriented towards
the definition of fine-scale molecular events, such as extracellular
matrix (ECM) remodeling, adhesion of cancer cells, and individual
growth stages of the secondary tumor than were MDs or MD/
PhDs (Figures 2C and D). Both PhDs and MDs referred to Paget’s
‘‘seed and soil’’ hypothesis when discussing the seeding of cancer
cells and finding a niche (‘‘soil’’) for a new tumor (Figures 2B and
C). As expected, medically trained experts were more inclined to
comment on clinical issues, while biologists leaned towards
molecular events and mechanisms. In general, all experts agreed
on the important events in metastasis, but not on their order.
Expert-specific stories
The main discrepancy between reviewers was neither their
descriptions of individual steps nor their relative importance, but
in how they ordered those steps and the granularity of their
description of metastasis (Figure 3). Comparing ‘‘stories’’ provided
by the 28 experts with each other, we were surprised to find that
no two were identical. In their description of metastasis, experts
grouped the same symbols/events differently, they varied their
ordering of events, and often suggested recurrent events absent in
the outline that we showed them. While some disagreements were
minor, such as proposing that ‘‘some unknown extra steps occur
between these events,’’ others were substantial (see Figure 3A, B,
and C). Compare, for example, the ‘‘stories’’ provided by experts
14 and 26.
It was clear after 28 interviews that despite similarities, experts
think differently about metastasis. To quantify similarity and
dissimilarity between pairs of experts, we introduced a metric that
compares two series of elements (Figure 4A and ‘‘Materials and
Methods’’ section). This measure allows us to compute the
probability that a pair of randomly chosen experts agree on at least
k statements (k=0, 1, 2, …), or disagree on fewer than k statements
(see Figure 4B). The probability of agreement drops rapidly with
increasing values of k, while the probability of disagreement grows
more gradually to a rather large number of pairwise disputes
(.120). If these views were held to be exclusive and experts did not
allow alternative interpretations, we might observe a situation that
could be called ‘‘regulatory deadlock,’’ in which any researcher
could disagree with all others (Figure 4C) when reviewing their
models of metastasis in a manuscript submission or grant proposal.
Expert responses to specific questions
As we explained in ‘‘Materials and Methods’’, in the second part
of each interview, we asked experts about specific topics. Here we
examine five topics that experts discussed, pertinent to computa-
tional modeling: (1) definition of the process, (2) stage at which
metastasis is acquired, (3) importance of tropism, and (4)
connections that link metastasis with development and evolution.
Numbers following quotes in the text below are the number of
experts that nonexclusively mentioned the idea in question. Note
that these numbers should be interpreted as the salience of the
topic for that number of experts, which is less than the number
that would likely assent to the topic’s importance if presented to
them. All topics, grouped by expert, can be found in supplemen-
tary Dataset S1.
1. When asked, at the beginning of the interview, the simple
question ‘‘What is metastasis?’’ some experts defined it broadly
with respect to its disease domain (‘‘metastasis is part of cancer’’
(5)) and others by its formal structure (‘‘metastasis is a multistage
process’’ (6)). Some admitted, ‘‘it is not clear what it is’’ (3). Most,
however, also provided more specific diagnostics: defining it as
‘‘the spread [of cancer]’’ (15) or, alternately ‘‘the growth of a
secondary tumor’’ (10). Several mentioned specific ‘‘steps in the
process’’ or factors that should be distinguished in an appropriate
definition. These included ‘‘the difference between spread and
secondary tumor’’ (9), the particular ‘‘route’’ of the process (8), the
‘‘distant vs. regional’’ range of spread (5), and whether and how
clinical ‘‘detection’’ is possible (4).
2. Experts were asked at which stage they think a cancer cell
acquires metastatic abilities. This is a critical topic for modeling as
it can be seen as the start of the metastatic process. In this paper
we discuss the two main issues on which experts commented:
‘‘when’’ metastatic abilities are acquired and on what factors that
acquisition ‘‘depends.’’ (Some experts also commented on a third
category, ‘‘which cells’’, which we display in the supplementary
materials - Dataset S1.)
Many experts thought that cancer cells acquire metastatic
abilities ‘‘early, at the beginning’’ (12). Several others suggested
that ‘‘it varies’’ (10), or specifically that the acquisition took place
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Several suggested the more nuanced view that ‘‘the ability is pre-
present but changes [are] needed’’ (6). These could include non-
cancer mutations, or forces of stress and pressure on the cell.
Others concurred that metastatic abilities were acquired ‘‘after
mutations’’ (4), or either ‘‘early or after mutations’’ (3). A single
expert mentioned the dependence of metastatic ability on
‘‘selective pressure’’ and many simply stated that they did not
know (10). Six transposed the question to where the ability is
acquired by locating it within ‘‘cancer stem cells’’ (6).
More experts spontaneously noted that acquiring metastatic
ability has something to do with an ‘‘individual’s genetics’’ (6) than
with their ‘‘environment’’ (2). Most thought that acquiring the
ability depends on anatomical characteristics ranging from ‘‘cell
type’’ (6), ‘‘organ site’’ (1), ‘‘tissue stroma and microenvironment’’
(6) to proximity to ‘‘blood supply’’ (3) or the ‘‘extracellular matrix’’
(2) and the amount of local ‘‘biochemical signaling’’ (3). Others
viewed acquisition with regard to dynamic forces like ‘‘selection
pressure and microenvironment’’ (6) and ‘‘mutations and changes’’
(8). Many noted acquisition of these abilities hinged on the nature
of the tumor (‘‘tumor type, size or stage’’ (9)). A few also described
acquisition functionally—in terms of ‘‘loss of suppression’’ (2),
whether the cancer can ‘‘successfully evade the immune system’’
(2), its ‘‘ability to move and invade’’ (3) and to ‘‘pass thresholds and
barriers’’ (1). Many admitted nonspecifically that ‘‘many factors
throughout’’ (8) were involved, fewer that ‘‘it is random’’ (4), and
three confessed ignorance (3).
3. It is known that given the location of a primary tumor, cancer
tends to metastasize selectively into different body parts. This
phenomenon is termed tropism. Understanding how this selection
takes place is critical for modeling metastasis.
We asked experts about the basis for metastasis’ tropism and the
importance of the relationship between the metastatic cells and
their tumor of origin. Experts overwhelmingly associated the basis
of tropism with the ‘‘microenvironment’’ (17) of the secondary
tumor. Some more specifically detailed that it was involved with
‘‘circulation’’ (10) and ‘‘blood supply’’ (2). Some described the site
selection as a nonspecific ‘‘stickiness’’ (3) between primary and
secondary tumor sites, and others that it resulted from a process of
‘‘selection’’ (2).
Experts also discussed factors that involve the relationship
between primary and metastatic sites. Several mentioned the
relevance of the theory of ‘‘seed and soil’’ (7). Some specifically
located this relation in the ‘‘similar biology in primary and
metastatic sites’’ (7). Others suggested that the relation between
seed and soil implied a ‘‘developmental connection’’ (3), that the
sites shared ‘‘genetic’’ factors (4) or were linked via ‘‘chemical
communication’’ (4). Many experts felt unsure of the relationship,
citing ‘‘other factors’’ (6), a nonspecific ‘‘combination of things’’
(9), and that they simply did not know (10).
4. For many years there have been comments in the literature
[15,16] that the metastatic process resembles other processes such
as those of (embryonic) development and evolution. In computa-
tional modeling, these resemblances could be formalized and
exploited.
The relationship between metastasis and (embryonic) develop-
ment was the topic that produced the most closely related groups
of ideas discussed by experts. Most experts suggested that we
‘‘need to understand the connection between development and
metastasis’’ (12) or ‘‘cancer’’ in general (3). Nearly everyone noted
‘‘similarities between development and cancer and metastasis’’ (22)
(15 separately noted similarities between ‘‘development and
metastasis’’ and 14 between ‘‘development and cancer’’). More
specifically, several experts discussed that ‘‘cells use existing
mechanisms’’ (9) in the metastasis process. At the same time,
however, many noted key ‘‘differences between development and
cancer and metastasis’’ (12). Several noted that ‘‘development is
controlled whereas cancer is not’’ (10) and some of these and
others considered ‘‘specific issues on control loss’’ (10). A few also
claimed that ‘‘genetic changes’’ separate the two processes (3).
Most experts made ‘‘general comments’’ (18) of agreement
regarding the connection between the processes of metastasis and
evolution and many extensively discussed the apparent homology
between ‘‘natural selection’’ (17) and metastasis. A few experts also
noted that the process of metastatic ‘‘treatment is similar to
evolution’’ (3) in the way that cancers come to evade it. Some
experts explored ‘‘other evolutionary connections’’ (6).
What were experts certain about?
In total, we recorded 776 comments (27.7 per expert on
average), see Figure 5. The majority (715) framed comments about
the proposed topics in terms of positive knowledge claims
(‘‘agree’’), 43 expressed uncertainty (‘‘maybe’’), and only 18
mentioned ideas with which they disagreed (‘‘disagree’’). On
average, men generated slightly more comments than women (28
vs. 26 comments). Most of the positive comments (224) were about
the connection between metastasis and development. Specific
examples include: ‘‘Cancer stem cells are very different from
embryonic cells,’’ and ‘‘Embryonic cells are more related to adult
normal stem cells.’’ The least mentioned topic (70 comments) with
the most disagreement (5) concerned the connection between
metastasis and evolution. Categories that elicited the most
uncertainty were metastasis tropism factors (13 ‘‘maybe’’ com-
ments), and on what acquiring metastasis depends (12 ‘‘maybes’’).
See supplementary Dataset S1 for more detailed information.
Experts’ interests/responses in light of their backgrounds
Expert backgrounds, such as medical or biological training,
could influence views and convictions. To detect such trends, we
analyzed experts’ comments in the context of their backgrounds,
classifying experts by training, gender, time of training, and
institutional affiliation (Figure 6). These groups significantly differ
in their response to some specific issues, calculated with a x
2-test.
For example, women from our sample were more likely to define
metastasis as relating to secondary tumor growth than men
(p,.01; see supplementary materials for other specific differences).
Due to our small sample size, however, differences between groups
on the aggregated topics we report below were not statistically
significant and should be considered as merely suggestive. We
summarize these differences in terms of the percentage of
responses that would have occurred if every person had discussed
every issue mentioned by anyone. This calculation corresponds to
the percentage of ‘‘colored’’ squares from the matrix in Figure 6.
Across all groups, lower percentages suggest more diversity of
opinion. Differences between groups suggest that some groups
consider more issues than others.
When the definition of metastasis was raised, our respondents
discussed 72 out of 280 ‘‘possible’’ responses, or 26%. Those who
received their first advanced degree between 1986 and 1995
responded with the most issues regarding the definition of
metastasis (29% versus 26%), while MDs discussed the fewest
(20%). All groups of experts commented approximately equally on
the issue of ‘‘When is metastasis acquired’’ (61 out of 364=17%).
We collected the sparsest or most diverse pattern of response in
association with the topic ‘‘Acquiring metastasis depends on…’’
(76 boxes colored out of 532=14%). Experts who received their
training before 1986 commented on the greatest number of ideas
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commented with the least (25/209=12%).
PhDs mentioned the most ideas (27% of the PhD boxes are
colored) in discussing metastasis tropism factors (84 boxes colored
out of 364=23%), while MDs commented with fewest (16%). The
densest comments and most statistically significant variation across
groups occurred for topics related to ‘‘Metastasis and develop-
ment’’ (121 boxes colored out of 336=36%; see supplementary
materials for specific differences). PhDs (42%) and MD/PhDs
(43%) commented with the most ideas; and MDs commented with
the fewest (25%).
The sparsest comments came from the 1986–1995 training
group on the topic ‘‘Acquiring metastasis depends on…’’ (12%),
while the most dense commenting was provided by experts
educated before 1986 on the topic ‘‘Metastasis and development’’
(42%). Overall, PhDs and MD/PhDs commented with the most
ideas (24% and 25%), while MDs commented with fewer (19%).
This likely suggests that a clinical focus is less likely to measure,
identify or imagine subtle, microscopic stages internal to the
process of metastasis.
Integrating expert stories
If we simply counted ordered pairs of metastatic stages across
the entire pool of experts, we could identify those that occur most
frequently. These pairs indicate the mode of the agreement
distribution. We made an additional effort to create a Markov
model to integrate all expert scenarios. Our simple model
formalizes the precise distribution of agreement about the
progression of metastasis. It also suggests the logical consequences
that would result from following the divergent metastatic paths
hypothesized by different experts. As such, it creates a standard
against which experimental and observational data about
metastasis can be evaluated.
To introduce our model, we first illustrate three, simplified
scenarios in Figure 7. In the first (7A), five hypothetical experts
provide five stories, each involving five identically ordered stages.
In the second (7B), experts provide somewhat different stories and
in the third (7C), stories are dramatically different, random re-
orderings and deletions of stages. Panels 7D, E and F graph the
probability that a pair of randomly chosen experts from each
scenario would agree on at least k statements (compare with
Figure 4B). Panels 7G, H and I visualize transition probabilities in
consequence of a single transition for Markov models that
integrate all stories from each scenario. For example, 7G illustrates
how the Markov model for the ‘‘complete agreement’’ scenario
pools virtually all transition probability into the cells just right of
the diagonal such that each stage leads almost unequivocally to the
next. In contrast, the ‘‘random agreement’’ scenario gives rise to a
high-entropy pattern of transition probabilities pictures in 7I. The
‘‘moderate agreement’’ scenario of 7H is a more realistic situation,
with most of the transition probability pooling just above and
below the diagonal, between stages that most experts believe are
near one another.
We visualize the actual transition probabilities between real
stages of metastasis for one, two and 10 Markov transition steps in
Figure 8 (the data can be found in supplementary Datasets S2, S3,
S4, S5, S6). Expert consensus about metastasis corresponds to the
most probable path from ‘‘start’’ to ‘‘end’’ state. Specifically, this
highest-probability path follows the trajectory: ‘‘Start’’Rprimary
tumorRdetachmentRinvasionRbreach ECMRintravasationR
motilityRmigrationRextravasationRcolonizationRproliferation
RangiogenesisRmicrometastasisRmacrometastasisR‘‘end’’.
More interesting, however, are weaker links in the consensus
chain. Primary tumor nearly always begins the metastatic
sequence (except for those considering ‘‘liquid tumors’’ such as
leukemia) and micro- and macrometastasis nearly always end it.
Detachment from the primary tumor, however, does not lead to
invasion for all experts, but to motility, interactions with the
stroma, and other changes in the metastatic cell. Similarly, experts
note alternative sequences and supply novel stages at several points
in the middle of the metastatic process. This is especially true at
entry and exit of cancer from the circulatory system. The Markov
chain also suggests that the secondary tumors may spawn
secondary, tertiary and higher order metastases (this possibility
Figure 5. Agreement across experts by discussion topics. We grouped the comments of experts into several topics. Within each topic
(represented here by a row), an expert may have mentioned several ideas he or she agrees with, disagrees with, or is unsure about. This heat map
depicts the main topics for modeling the process and how many ideas under each topic every expert (columns: 1–28) discussed, along with their
agreement. An asterisk (*) indicates a topic whose frequency of mention was statistically significant compared to the null model of a uniform
distribution of comments (see Table S1). Abbreviations: Def=Definition, Dev=Development, Env=Environment, Evol=Evolution, Met=Metastasis,
Mic=Micro, Trop=Tropism.
doi:10.1371/journal.pcbi.1002132.g005
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knowledge explicitly). The formal model also highlights the
possibility that metastasis may terminate at an earlier state. For
example, a cell disconnected from the primary tumor may fail to
enter the bloodstream or find a suitable niche for establishing a
new colony.
Figure 6. A map of comments provided by experts with details on expert backgrounds. The ideas discussed by the experts for three main
interview topics were (A) what acquisition of metastasis requires, (B) when metastasis is acquired, and (C) what factors affect preferential choice of
specific tissues/organs by metastatic cells (tropism). Color-filled squares indicate that the corresponding idea (one per row) was discussed by the
corresponding expert (one per column). The responses have been grouped to illustrate the variance for ‘‘PhDs vs. MDs vs. MD/PhDs’’ and experts that
received their first aforementioned degree ‘‘before 1986 vs. between 1986 and 1995 vs. after 1995.’’ On the top, the expert ID number can be found
followed by four rows of color-coded squares, indicative of four classifications associated with each expert: (1) ‘‘The-University-of-Chicago vs.
elsewhere’’; (2) when experts received their first professional degree—‘‘before 1986 vs. between 1986 and 1995 vs. after 1995’’; (3) ‘‘men vs. women’’;
(4) and the nature of their advanced degrees—‘‘PhDs vs. MDs vs. MD/PhDs.’’
doi:10.1371/journal.pcbi.1002132.g006
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possible shifts between metastatic stages. As each transition
involves the multiplication of prior and current transition
probabilities, after 10 transitions, the location of the model is
much less certain—and more evenly uncertain—than after 1 or
2 transitions. Not surprisingly, most of the stages suggested by
individual experts have much lower transition probabili-
ties because they were not conceptually available to most
experts.
The power of our model is not simply to quantify consensus
and provide another illustration of expert stories, but to
integrate and formalize those stories such that new data can
Figure 7. Three hypothetical scenarios involving five experts, each providing a story containing five stages. The three scenarios
illustrate situations of (A) ‘‘complete agreement’’, (B) ‘‘moderate agreement’’, and (C) ‘‘random agreement.’’ Panels D, E and F illustrate the probability
of agreement and disagreement between two randomly chosen experts on at least k statements for each scenario (see Figure 4B). Panels G, H and I
render heat maps to illustrate the transition probability matrices after a single Markov chain transition under each scenario. Each stochastic matrix is
square, non-negative and organized in the following way. The i
th row of the matrix provides probabilities of transitions from state i to all other states
of the model. The sum of probabilities in each row is therefore equal to 1.
doi:10.1371/journal.pcbi.1002132.g007
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conclusion can be drawn. To do this, the a posteriori
probabilities we present here would become the prior probabil-
ities in a new model, and data from experiment or observation
would supply the counts from which new posterior probabilities
could be calculated.
Our model can be easily expanded to continuous-time Markov
chains if precise time information was attached to metastatic stages
in the experimental or observational data to be evaluated. We
could use more complicated Markov models, for example,
introducing higher-order dependencies between states of the
Markov chain, for example, assuming
Figure 8. Heat maps that visualize the transition probability matrices in our Markov model of metastasis after n Markov chain
transitions (n=1, 2, 10); and a plot of probabilities associated with reaching each state after n chain transitions. (A) Stochastic matrices
are organized as in Figure 7G, H and I: each stochastic matrix is square, non-negative and organized such that the i
th row of the matrix provides
probabilities of transitions from state i to all other states in the model and the sum of each row is equal to 1. The three matrices show the transition
probabilities from states i to state j after one (P
1), two (P
2), and ten (P
10), transition steps of the Markov process. The labels, ‘‘Start’’ and ‘‘End’’
correspond to the generating and absorbing states of the Markov chain, respectively. The rest of the labels indicate metastasis stages that were
suggested by the authors (in blue) and by individual experts (in red). (B) The probability of finding the Markov process in a given state at transition n
(n=1, 2, …, 50) is given by pj~
P N
i~0
lip
(n)
ij . Here L is the distribution over all states at the beginning of the chain, and P
n=[pij
(n)] is the transition
probability matrix after the n
th transition (obtained by raising matrix P to n
th power). This figure demonstrates the decreasing probability that expert
intuition about metastasis lands in any particular state at any particular stage. Note that even after 50 transitions there is a substantial probability that
the chain would not reach the ‘‘End’’ state.
doi:10.1371/journal.pcbi.1002132.g008
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Moreover, the model could be extended to consider partially
observed data [20].
Our current model does not account for the fact that some
experts collapsed metastatic stages or suggested that they occur in
parallel. We could augment the model to accommodate this by
creating sub-chains (i.e., start-intravasation, end-intravasation) that
include within them all possible sub-stages, and by allowing the
introduction of new states to represent simultaneous processes.
One might also want to incorporate various expert beliefs about
particular issues associated with and affecting certain stages of
metastasis (for example, beliefs depicted in Figures 5, 6 and the
supplementary files Dataset S1 and Figure S2). Such complexity,
however, is beyond the scope of this paper.
Discussion
A reader may wonder how much time a computational
biologist, immersed in designing, streamlining and evaluating
mathematical models, should spend learning what biological or
clinical experts think. In their search for conceptual clarity,
theorists across the sciences feel a natural ambivalence about
engaging with the diversity and conflict among perspectives held
by experimentalists and observers. We argue passionately,
however, that computational biologists, research clinicians, and
scientists more broadly should worry about biological and clinical
assumptions, probability distributions over expert opinions and
subjective prior probabilities associated with conflicting intuitions.
If a mathematical model is likened to a building, expert
assumptions are the ground beneath. If the underlying soil is
swamp, the edifice—the model and its resulting inferences—will
sink despite all effort and elegance invested in its design.
In the interest of scientific advance and the computational
modeling we believe can accelerate it, we propose that
assumptions and hunches be harvested systematically and made
electronically available for computational scientists. We believe
that if expert knowledge and certainty were referenced as routinely
as newly identified nucleotide sequences are queried against
established genomes, computational models would be much more
scientifically relevant and powerful. Models that take the certainty
of assumptions into account will be able to use widely established
certainty as an effective modeling constraint. Even more
important, computational models will be able to work out the
implications and arbitrate between more and less plausible
intuitions on the path to greater scientific agreement and better
founded certainty. This could be especially significant in emerging
areas that concern complex phenomenon like metastasis where
much diversity of opinion remains.
How to harvest insights at large scales remains an open
problem, but a solvable one. Ideally, many experts in the field
should be interviewed. It is rarely feasible to query them all, and so
a subset should be sought that maximizes social and educational
diversity. This will help to increase the range of independent
experiences with the same natural phenomenon. When research-
ers are part of a close community, they often share assumptions
converged upon through communication and social influence. We
also believe that emerging methods of harvesting expert
assumptions and intuitions show promise, including crowdsour-
cing and mining text from articles, presentation slides and science
blogs.
The results we obtained in this study did not match our
expectations. We expected some disagreement, but we did not
anticipate the level of conceptual diversity encountered. We
anticipated that experts would agree on the majority of issues,
while minor matters would generate mild deviation. Instead, we
found widely divergent stories with each story distinct from every
other. Admittedly, many of these differences were small, as the
addition of precise intermediate steps in the metastatic process by
molecular and cell biologists. Other differences, however, were
large, including whether or not secondary tumors could lead to
‘‘tertiary’’ metastasis. We were also impressed by the positive
conviction experts expressed—strong beliefs largely incompatible
across scientists and yet perceived and presented as representing
the field [20]. This conclusion was partially conditioned on the
nature of the field. Metastasis is a complex, multi-faceted
phenomenon, investigated by a broad federation of overlapping
scientific communities. Nevertheless, many research areas in
biomedicine approximate these conditions, including investiga-
tions of virtually every complex disorder resulting from a
combination of multiple genetic and environmental factors like
schizophrenia, coronary heart disease or asthma.
Our analysis also suggests the importance of developing
improved methods to analyze competing scientific accounts. In
this paper, we only examine pairs of elements, and yet these pairs
are part of larger sequences that intersect one another. Previous
research that renders narratives as sequences and intersecting
networks of claims [21–24] suggests exciting possibilities regarding
how to identify important subsequences and the centrality of
elements in theoretical narratives. We will explore these and other
possibilities in future research. Our Markov model provides a first
step to formally integrate expert consensus surrounding the stages
of metastasis and organize a set of hypotheses against which future
experimental and observed data on metastasis can be evaluated.
We argue that our method could also enable researchers to gain
insight into the diversity of accounts beyond the realms of science.
These include historians’ competing narratives about a past event,
eyewitness reports of a current one, or judicial opinion about a
bundle of related legal cases. Markov model formalism can
represent not only narrative or logical sequences, but also
continuous-space events like the diffusion of an innovation or fad.
Our analysis has broad practical implications for understanding
mechanisms through which scientific ideas succeed or fail.
Mathematical models will fail if they are based on false biological
assumptions. Nevertheless, well-executed grant proposals or
manuscripts involving models can also be rejected because they
are based on reasonable assumptions not shared by the reviewer.
Our analysis of the distribution of expert stories regarding cancer
metastasis demonstrates that the probability of disagreement on
assumptions is high for any pair of experts (see Figure 4B).
Furthermore, when multiple experts review a manuscript, the
probability that at least one opposes some of the assumptions in
the manuscript approaches unity. Nevertheless, proposals are
funded and articles published, implicating a pragmatic social
process through which experts certify research with which they
disagree. It is unclear, however, what rules guide this process. For
example, it may be that research at the boundaries between
established perspectives is discounted [25], even though this is the
position at which mathematical models and integrative theory
could be most useful for the advancement of science.
Our analyses also suggest testable hypotheses about the
distribution of expert opinions across the scientific community.
We conjecture that in the total population of expert ideas,
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Zipfian or zeta distribution that follows a power law with a heavy
tail. In other words, the probability that a particular assumption is
shared by k experts in the general population of scientists is
proportional to ck
2c, where c is a positive real parameter that is
greater or equal to 1 and c is a normalizing constant ensuring that
the distribution sums to 1 over all allowable k’s (1, 2, 3, …). This
suggests that a few ideas are widely shared, but that many more
are rare, held only by individual scientists or small groups. We
base this conjecture on the observation that the generation and
propagation of assumptions employs mechanisms similar to those
involving the popularity of words in human language, the
distribution of which served as the basis for Zipf’s law. If this
conjecture were true, assumptions from a very large number of
experts would be required to approximate the collective
knowledge of all experts with fidelity. On the other hand, common
assumptions could be captured from analysis of a small number of
interviews.
The most critical and vexing issue involves the relationship
between the distribution of expert opinion and biological reality. It
is unclear whether common ideas result from independent
experiences with biological phenomena or represent axioms
around which the field has converged as a function of shared
training, shared tools, and communication. This key issue merits
separate investigation, but regardless of the answer, idiosyncratic
knowledge held by scientists in the tail of the distribution cannot
be the result of an artificial convergence process. While some of
this conceptual idiosyncrasy is invariably the result of logical or
experimental error, there is likely much sound, but rare insight in
it that, when harvested and incorporated into formal hypotheses
like our Markov model, could accelerate the advancement of
science.
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